Initial efficacy data for Mythic’s pH-engineered cMET-directed antibody-drug conjugate (ADC) demonstrates meaningful anti-tumor activity across all cMET expression levels, histologies, and actionable ...

WALTHAM, Mass., May 01, 2025--(BUSINESS WIRE)--Mythic Therapeutics, a clinical-stage biotechnology company developing next-generation antibody-drug conjugate (ADC) therapies for the treatment of a ...

However, the rise of consumerism has also led to an increased misuse of ancient knowledge, he said. Dr V Anuradha, vice-president, The Mythic Society, said there was a need for an extensive study of ...

The Mythic Society had organised a seminar titled 'Early Kadambas and their Times' last month, followed by a public viewing of the same on enlarged screens.

It’s a Saturday. The midmorning sun beats down on the 40-odd people alighting from a bus and fanning across the quiet interiors of the Mythic Society library housed in the Daly Memorial Hall on ...

WALTHAM, Mass.--(BUSINESS WIRE)--Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment ...